This track explores cutting-edge developments in non-invasive diagnostic technologies, including imaging modalities, wearable devices, and breath analysis systems. By minimizing patient discomfort and enhancing early detection capabilities, these innovations are transforming the diagnostic landscape for respiratory diseases such as COPD, asthma, and interstitial lung diseases.
Who Can Submit Abstracts:
Researchers developing novel diagnostic tools or methodologies.
Clinicians implementing non-invasive diagnostics in clinical practice.
Medical device manufacturers with expertise in innovative respiratory diagnostic technologies.
Who Can Deliver the Talk:
Pulmonologists and respiratory specialists.
Biomedical engineers and diagnostic technology developers.
Public health experts with experience in implementing diagnostics at scale.
What Delegates Will Gain:
Insight: Comprehensive understanding of non-invasive diagnostic advancements.
Applications:Strategies to integrate non-invasive diagnostics into clinical practice.
Connections: Networking with leading experts in diagnostics innovation.
This track examines the integration of artificial intelligence (AI) and machine learning (ML) in respiratory medicine. Discussions will include AI-driven diagnostic tools, predictive analytics, and personalized treatment plans, emphasizing their potential to enhance accuracy, efficiency, and outcomes in respiratory care.
Who Can Submit Abstracts:
Data scientists working on AI/ML models in healthcare.
Researchers studying AI applications in respiratory diagnostics or treatment.
Healthcare IT professionals implementing AI solutions in medical systems.
Who Can Deliver the Talk:
AI and ML experts in medical research.
Clinicians utilizing AI-based systems in practice.
Policy advisors addressing AI integration in healthcare systems.
What Delegates Will Gain:
Knowledge: Emerging AI/ML applications and their clinical relevance.
Tools: Practical insights into deploying AI solutions for respiratory care.
Collaboration: Opportunities to connect with AI researchers and technology leaders.
This track focuses on the discovery and validation of novel biomarkers for early detection, disease progression monitoring, and therapeutic response in respiratory conditions. Topics include proteomic, genomic, and metabolomic biomarkers with potential for clinical application.
Who Can Submit Abstracts:
Researchers working on biomarker discovery and validation.
Academic institutions conducting translational respiratory research.
Biotechnology companies developing biomarker-based diagnostic assays.
Who Can Deliver the Talk:
Pulmonary researchers specializing in biomarker identification.
Laboratory scientists with expertise in molecular diagnostics.
Clinicians utilizing biomarker-based tools in practice.
What Delegates Will Gain:
Understanding:The latest advancements in respiratory biomarkers.
Opportunities: Insights into clinical and translational research applications.
Networking: Access to partnerships with experts in biomarker technology.
This track delves into the evolving field of inhalation therapies, including advancements in drug formulations, delivery devices, and personalized approaches for treating respiratory diseases. The session highlights innovations addressing efficiency, patient adherence, and therapeutic outcomes.
Who Can Submit Abstracts:
Researchers in pharmaceutical development for inhaled therapies.
Engineers designing next-generation inhalation devices.
Clinicians assessing inhalation therapy efficacy in real-world settings.
Who Can Deliver the Talk:
Pharmacologists specializing in inhalation drug development.
Pulmonologists focusing on therapeutic delivery methods.
Medical device developers innovating respiratory care tools.
What Delegates Will Gain:
Innovation: Insights into next-generation inhalation therapies.
Applications: Practical guidance for integrating advanced therapies into practice.
Engagement: Opportunities to collaborate with industry leaders in inhalation research.
This track highlights groundbreaking advancements in gene therapy and regenerative medicine, focusing on their potential to treat chronic and hereditary respiratory diseases. Discussions will include novel gene-editing techniques, stem cell therapies, and the challenges of translating these innovations into clinical care.
Who Can Submit Abstracts:
Scientists researching gene-editing technologies such as CRISPR in respiratory diseases.
Biotech companies developing regenerative therapies for lung conditions.
Clinicians involved in trials of gene or cell-based therapies.
Who Can Deliver the Talk:
Geneticists and molecular biologists specializing in gene therapy.
Clinicians pioneering regenerative medicine applications.
Industry leaders in advanced therapeutics development.
What Delegates Will Gain:
Breakthroughs: Exposure to the latest advances in gene and regenerative therapies.
Challenges: Understanding the hurdles of clinical translation and implementation.
Partnerships: Building connections with leaders in cutting-edge respiratory care technologies.
This track explores the significant global impact of chronic respiratory diseases (CRDs) such as asthma, COPD, and pulmonary fibrosis. Experts will discuss epidemiological trends, socio-economic implications, and the urgent need for coordinated strategies to address this growing public health challenge.
Who Can Submit Abstracts:
Epidemiologists studying trends and risk factors of CRDs.
Public health professionals focused on global respiratory disease initiatives.
Clinicians managing CRDs and their associated comorbidities.
Who Can Deliver the Talk:
Pulmonologists specializing in chronic respiratory diseases.
Researchers presenting data on the global burden of CRDs.
Policyadvisors advocating for improved CRD management strategies.
What Delegates Will Gain:
Perspective: A comprehensive understanding of the global burden of CRDs.
Action Plans: Tools to design effective public health interventions for CRDs.
Collaboration: Opportunities to connect with global experts in respiratory health.
This track investigates the link between environmental factors—such as air pollution, climate change, and industrial exposures—and respiratory health. Discussions will focus on mitigating environmental risks and developing policies to protect vulnerable populations.
Who Can Submit Abstracts:
Environmental scientists studying pollutants’ effects on respiratory health.
Researchers focusing on the health consequences of climate change.
Policy developers working on environmental regulations to reduce respiratory risks.
Who Can Deliver the Talk:
Environmental health scientists and epidemiologists.
Pulmonologists addressing environmentally induced respiratory diseases.
Advocates for climate-resilient health policies.
What Delegates Will Gain:
Knowledge: Insights into environmental drivers of respiratory diseases.
Policy Tools: Understanding frameworks for environmental risk mitigation.
Networking: Building partnerships with environmental and health experts.
This track focuses on the long-term respiratory impacts of COVID-19, including post-acute sequelae (Long COVID) and its implications for healthcare systems. Attendees will explore management strategies and emerging research on improving outcomes for post-COVID respiratory patients.
Who Can Submit Abstracts:
Clinicians managing post-COVID respiratory complications.
Researchers investigating Long COVID respiratory outcomes.
Public health officials addressing healthcare burdens post-COVID.
Who Can Deliver the Talk:
Pulmonologists specializing in post-COVID care.
Researchers studying respiratory sequelae of COVID-19.
Rehabilitation specialists with expertise in respiratory recovery.
What Delegates Will Gain:
Management Strategies: Best practices for addressing post-COVID respiratory health.
Emerging Research: Updates on Long COVID and its implications.
Collaboration: Opportunities to engage with multidisciplinary experts tackling post-COVID challenges.
This track addresses the resurgence of tuberculosis (TB), driven by factors such as drug resistance, urbanization, and global migration. Discussions will cover advancements in diagnostics, treatment protocols, and public health strategies to combat TB effectively.
Who Can Submit Abstracts:
Researchers focusing on TB diagnostics and treatments.
Public health professionals working on TB control programs.
Clinicians addressing drug-resistant TB in practice.
Who Can Deliver the Talk:
Infectious disease specialists focused on TB.
Public health leaders in TB eradication programs.
Epidemiologists studying TB resurgence trends.
What Delegates Will Gain:
Knowledge: Insights into the factors driving TB resurgence.
Solutions: Tools to improve TB diagnosis and treatment.
Opportunities: Connections with stakeholders in global TB initiatives.
This track explores innovative public health strategies and interventions for reducing smoking rates globally. Topics include the role of policies, community programs, and emerging technologies in promoting smoking cessation and improving respiratory health.
Who Can Submit Abstracts:
Public health researchers studying the effectiveness of smoking cessation programs.
Clinicians implementing smoking cessation interventions.
Policy advisors developing anti-smoking regulations.
Who Can Deliver the Talk:
Public health experts specializing in smoking cessation initiatives.
Behavioral scientists addressing smoking addiction.
Policymakers advocating for tobacco control measures.
What Delegates Will Gain:
Best Practices: Proven strategies for implementing smoking cessation programs.
Innovative Tools: Insights into technology-driven interventions for smoking cessation.
Collaboration: Opportunities to connect with leaders in tobacco control and respiratory health advocacy.
This track explores the transformative potential of precision medicine in chronic obstructive pulmonary disease (COPD) management. From genomics-based diagnostics to personalized treatment plans, attendees will learn about tailored interventions that improve patient outcomes and reduce disease burden.
Who Can Submit Abstracts:
Researchers investigating genetic and molecular markers for COPD.
Clinicians implementing precision medicine approaches in COPD care.
Industry professionals developing targeted therapies for COPD patients.
Who Can Deliver the Talk:
Pulmonologists specializing in COPD.
Geneticists working on biomarker-driven COPD treatments.
Pharmaceutical leaders developing personalized respiratory care solutions.
What Delegates Will Gain:
Insights: Advances in precision medicine and their application in COPD care.
Clinical Strategies: Guidance on incorporating precision techniques into practice.
Collaboration Opportunities: Connections with experts in targeted COPD research.
This track addresses the challenges of translating research advancements into practical solutions for managing severe asthma. Topics include biologic therapies, phenotyping, and personalized treatment approaches that improve symptom control and quality of life.
Who Can Submit Abstracts:
Researchers studying severe asthma phenotypes and treatment responses.
Clinicians managing severe asthma patients in specialized clinics.
Biotech professionals developing biologic therapies for asthma.
Who Can Deliver the Talk:
Pulmonologists and allergists specializing in asthma care.
Researchers focused on clinical trials for severe asthma therapies.
Industry leaders in biologic and advanced asthma treatments.
What Delegates Will Gain:
Clinical Knowledge: Practical insights into severe asthma management.
Access to Innovations: Updates on emerging therapies and treatment strategies.
Networking: Engagement with asthma specialists and thought leaders.
This track highlights the importance of a multidisciplinary approach to diagnosing and treating pulmonary fibrosis. Discussions will focus on collaboration among pulmonologists, radiologists, pathologists, and other specialists to improve patient outcomes.
Who Can Submit Abstracts:
Researchers exploring novel therapies and diagnostic tools for pulmonary fibrosis.
Multidisciplinary teams presenting case studies or collaborative care models.
Clinicians managing pulmonary fibrosis patients in integrated care settings.
Who Can Deliver the Talk:
Pulmonologists and thoracic radiologists specializing in interstitial lung diseases.
Pathologists contributing to pulmonary fibrosis diagnosis.
Researchers working on innovative treatments for fibrosis.
What Delegates Will Gain:
Collaboration Models: Understanding the value of multidisciplinary care.
Diagnostic Expertise: Updates on imaging and biopsy techniques.
Therapeutic Advances: Insights into emerging treatments and clinical trials.
This track focuses on the latest breakthroughs in early detection and treatment of lung cancer. Attendees will explore advancements in low-dose CT screening, biomarker-driven diagnostics, immunotherapy, and personalized treatment strategies that are revolutionizing lung cancer care.
Who Can Submit Abstracts:
Researchers developing innovative diagnostic or therapeutic tools for lung cancer.
Clinicians implementing immunotherapies or targeted treatments.
Industry professionals advancing imaging and molecular technologies.
Who Can Deliver the Talk:
Oncologists specializing in lung cancer care.
Radiologists and pathologists working on early detection methodologies.
Pharmaceutical experts leading immunotherapy and precision oncology research.
What Delegates Will Gain:
Early Detection Insights: Knowledge of advancements in lung cancer screening.
Therapeutic Updates: Innovations in targeted and immunotherapeutic treatments.
Collaboration Opportunities: Networking with leading experts in lung cancer research.
This track emphasizes strategies to enhance respiratory rehabilitation programs for patients with chronic respiratory conditions. Topics include patient-centric approaches, innovative rehabilitation techniques, and integrating technology to improve adherence and outcomes.
Who Can Submit Abstracts:
Clinicians designing or implementing respiratory rehabilitation programs.
Researchers studying the efficacy of rehabilitation interventions.
Healthcare professionals integrating technology into rehabilitation strategies.
Who Can Deliver the Talk:
Pulmonary rehabilitation specialists.
Physical therapists with expertise in respiratory care.
Researchers and technologists advancing rehabilitation tools.
What Delegates Will Gain:
Practical Tools: Strategies for creating effective and engaging rehabilitation programs.
Patient-Centric Models: Insights into personalized rehabilitation approaches.
Technology Integration: Understanding how digital tools enhance rehabilitation outcomes.
This track addresses the growing threat of antimicrobial resistance (AMR) in respiratory infections, such as pneumonia and tuberculosis. It highlights strategies for early detection, antibiotic stewardship, and innovative approaches to developing novel treatments to combat AMR.
Who Can Submit Abstracts:
Researchers studying mechanisms of antimicrobial resistance in respiratory pathogens.
Clinicians implementing antibiotic stewardship programs.
Biotech professionals developing new antimicrobials or alternative therapies.
Who Can Deliver the Talk:
Infectious disease specialists focused on respiratory infections.
Microbiologists researching resistant pathogens.
Public health advocates working on AMR policy and awareness campaigns.
What Delegates Will Gain:
Understanding: Key insights into the drivers of AMR in respiratory diseases.
Solutions: Strategies to mitigate resistance through innovative therapies and policies.
Collaboration: Connections with leaders in AMR research and prevention.
This track explores the unique challenges of managing respiratory health in aging populations. Topics include age-related physiological changes, chronic disease management, and interventions to improve respiratory function and quality of life for older adults.
Who Can Submit Abstracts:
Researchers studying age-related respiratory health changes.
Geriatricians addressing respiratory comorbidities in older adults.
Public health professionals focusing on aging-related healthcare challenges.
Who Can Deliver the Talk:
Pulmonologists with expertise in geriatric respiratory care.
Geriatricians and physiologists specializing in aging populations.
Researchers exploring interventions to maintain respiratory health in older adults.
What Delegates Will Gain:
Knowledge: Insights into the impact of aging on respiratory function.
Tools: Evidence-based approaches to managing respiratory health in older adults.
Connections: Engagement with experts in geriatric respiratory care.
This track examines respiratory diseases caused by occupational exposures, such as silicosis, asbestosis, and work-related asthma. Discussions focus on prevention strategies, early detection, and comprehensive care for affected individuals.
Who Can Submit Abstracts:
Researchers studying occupational respiratory diseases and their risk factors.
Occupational health professionals developing workplace safety protocols.
Clinicians managing occupational respiratory conditions.
Who Can Deliver the Talk:
Occupational medicine specialists.
Pulmonologists treating work-related respiratory illnesses.
Public health professionals addressing workplace health policies.
What Delegates Will Gain:
Prevention Strategies: Tools for reducing workplace exposure to respiratory hazards.
Early Detection Insights: Understanding how to identify occupational respiratory diseases promptly.
Policy Development: Guidance on shaping workplace health and safety regulations.
This track focuses on improving respiratory health outcomes in children, addressing conditions such as asthma, cystic fibrosis, and congenital respiratory disorders. Emphasis will be placed on early diagnosis, advanced treatments, and holistic approaches to pediatric respiratory care.
Who Can Submit Abstracts:
Pediatric pulmonologists researching childhood respiratory diseases.
Clinicians treating respiratory conditions in children.
Researchers developing innovative diagnostic or therapeutic tools for pediatric populations.
Who Can Deliver the Talk:
Pediatric pulmonologists and healthcare providers.
Researchers advancing pediatric respiratory diagnostics and treatments.
Public health specialists focusing on respiratory health in children.
What Delegates Will Gain:
Clinical Knowledge: Updates on pediatric respiratory disease management.
Technological Insights: Exposure to emerging tools for diagnosing and treating respiratory conditions in children.
Collaborative Opportunities: Connections with leaders in pediatric respiratory care.
This track explores the transformative role of telemedicine and remote monitoring technologies in managing respiratory diseases. Topics include virtual consultations, wearable devices, and digital health platforms that improve access to care and patient outcomes.
Who Can Submit Abstracts:
Healthcare providers implementing telemedicine solutions for respiratory care.
Researchers studying the effectiveness of remote monitoring tools.
Technologists developing digital health platforms for respiratory diseases.
Who Can Deliver the Talk:
Pulmonologists utilizing telemedicine in clinical practice.
Developers of wearable devices and digital platforms for respiratory monitoring.
Public health leaders advocating for telehealth adoption.
What Delegates Will Gain:
Technological Awareness: Understanding the latest innovations in telemedicine and remote monitoring.
Practical Applications: Strategies to integrate telehealth into respiratory care.
Engagement: Opportunities to collaborate with technology developers and early adopters of telemedicine.